NFKB1 and breast cancer: In breast cancer, the downregulation of IκBα and the consequent activation of NF-κB, induces EMT and the secretion of molecules that promote cell migration and motility (Chua et al., 2007; Pires et al., 2017; Hsu et al., 2018).